Evidence map›Paper›PMID 41756699›Full record

ArticleClinical case reports2026

Coexistence of Friedreich's Ataxia and Esophageal Cancer: A Case Report.

Alireza Mehrban, Abdolreza Babamahmoodi, Mohammad Taghi Hamidian, Bahar Amiri, Parand Ramzani, Mehdi Karimi

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alireza MehrbanClinical Department, Amol Campus of Medicine Mazandaran University of Medical Sciences Sari Iran.
Abdolreza BabamahmoodiAntimicrobial Resistance Research Center, Communicable Diseases Institute Mazandaran University of Medical Sciences Sari Iran.ORCID https://orcid.org/0000-0002-3730-5268
Mohammad Taghi HamidianBabol University of Medical Sciences Babol Iran.ORCID https://orcid.org/0000-0002-4397-1048
Bahar AmiriStudent Research Committee Lorestan University of Medical Sciences Khorramabad Iran.ORCID https://orcid.org/0009-0008-1842-1520
Parand RamzaniBabol University of Medical Sciences Babol Iran.
Mehdi KarimiFaculty of Medicine Bogomolets National Medical University Kyiv Ukraine.ORCID https://orcid.org/0009-0006-4388-0214

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Friedreich's ataxia (FA) is a rare autosomal recessive neurodegenerative disorder. Although FA is frequently associated with cardiomyopathy and diabetes mellitus, its coexistence with solid malignancies is exceptionally rare. To date, only a limited number of gastrointestinal cancers have been reported in patients with FA. This case report presents the first documented occurrence of esophageal squamous cell carcinoma (ESCC) in a genetically confirmed FA patient, highlighting the diagnostic challenges and therapeutic considerations encountered in this unique clinical setting. A 48-year-old Iranian man with a 29-year history of Friedreich's ataxia presented with an 8-month history of progressive dysphagia, recurrent hematemesis, and recent onset of complete aphagia. On examination, he was cachectic and exhibited severe alopecia, kyphoscoliosis, dysarthria, and a non-ambulatory status. Laboratory evaluation demonstrated profound anemia and elevated alkaline phosphatase levels. Upper gastrointestinal endoscopy revealed a circumferential, obstructing mass in the mid-esophagus, and histopathological analysis confirmed moderately differentiated ESCC. Given the patient's advanced frailty, underlying cardiomyopathy, and severe malnutrition, curative chemoradiotherapy was deemed contraindicated. Palliative management included blood transfusion, nasogastric decompression, and placement of an esophageal stent. Despite these supportive interventions, the patient experienced hemodynamic instability and progressive neurological deterioration, ultimately succumbing to disease progression.

Indexed as

case reportdysphagiaesophageal cancerFriedreich ataxiahealthcare disparities

Identifiers

PMID41756699
PMCPMC12932118

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.